1)Masuda, T., S. Matsushita, M.J. Kuroda, M. Kannagi, K. Takatsuki, and S. Harada. 1990. Generation of neutralization-resistant HIV-1 in vitro due to amino acid interchanges of third hypervariable env region. J. Immunol. 145: 3240-3246.
2) El-Farrash, M.A., M.J. Kuroda, T. Kitazaki, T. Masuda, K. Kato, M. Hatanaka, and S. Harada. 1994. Generation and characterization of a human immunodeficiency virus type 1 (HIV-1) mutant resistant to an HIV-1 protease inhibitor. J. Virol. 68: 233-239.
3) Maeda, Y., M. Foda, S. Matsushita, and S. Harada. 2000. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1a. J. Virol. 74: 1787-1793.
4) Roche, S., and Y.Gaudin. 2002. Characterization of the equilibrium between the native and fusion-inactive conformation of rabies virus glycoprotein indicates that the fusion complex is made of several trimers. Virology 297: 128-135.
5) Plonsky, I., and J. Zimmerberg. 1996. The initial fusion pore induced by baculovirus GP64 is large and forms quickly. J. Cell Biol. 135: 1831-1839.
6) Markovic, I., E. Leikina, M. Zhukovsky, J. Zimmerberg, and L.V.Chernomordik. 2001. Synchronized activation and refolding of influenza hemagglutinin in multimeric fusion machines. J. Cell Biol. 155: 833-844.
7) Gibbons, D.L., I. Erk, B. Reilly, J. Navaza, M. Kielian, F.A. Rey, and J. Lepault. 2003. Visualization of the target-membrane-inserted fusion protein of Semliki Forest virus by combined electron microscopy and crystallography. Cell 114: 573-583.
8) Song, W., S. Yahara, Y. Maeda, K. Yusa, Y. Tanaka, and S. Harada. 2001. Enhanced infection of an X4 strain of HIV-1 due to capping and colocalization of CD4 and CXCR4 induced by capsianoside G, a diterpene glycoside. Biochem. Biophys. Res. Commun. 283: 423-429.
9) Layne, S.P., M.J. Merges, M. Dembo, J.L. Spouge, and P.L. Nara. 1990. HIV requires multiple gp120 molecules for CD4-mediated infection. Nature 346: 277-279.
10) Harada, S., T. Akaike, K. Yusa, and Y. Maeda. 2004. Adsorption and infectivity of human immunodeficiency virus type 1 are modified by the fluidity of the plasma membrane for multiple-site binding. Microbiol. Immunol. 48: 347-355.
11) Harada, S., K. Yusa, and Y. Maeda. 2004. Heterogeneity of envelope molecules shown by different sensitivities to anti-V3neutralizing antibody and CXCR4 antagonist regulates the formation of multiple-site binding of HIV-1. Microbiol. Immunol. 48: 357-365.